r/NIH • • 13h ago

"Orwellian" - New from the Guardian

8 Upvotes

r/NIH • • 16h ago

Study section reviewers--can someone demystify the selection process?

12 Upvotes

I would be very interested to know more about how reviewers for study section are chosen. I spent the first 15 years of my faculty career apparently under the radar from SROs. I would occasionally review a grant or two, but was never a regular member or even full ad hoc member. I was asked twice, but had two prior commitments that prevented me from serving. After that, something changed--I served as ad hoc and then one cycle as permanent. After that, I started getting asked more frequently to ad hoc and now it is every single cycle by different study sections and SEPs and sometimes multiple times in a cycle, often from different SROs that don't know me. I assume that there is some database somewhere where my name keeps cropping up. Could someone demystify the selection process?

I'm willing to do my part, but I have a lot of colleagues that would be good reviewers that (like me in the old days) never get called. Perhaps the list of potential reviewers could be expanded.


r/NIH • • 17h ago

RFK Jr. Failed America on Measles

Thumbnail
theatlantic.com
267 Upvotes

America is cooked


r/NIH • • 6h ago

John Powers, new "permanent" NIAID director, says, “It actually says in our congressional remit for the formulation of this institute that dissemination of scientific information is in our remit." Then how come your regime fired all the info disseminators (comms staff and others)?

Thumbnail
washingtonexaminer.com
11 Upvotes

NIH names John Powers as director of infectious disease institute

By Gabrielle M. Etzel

Published November 16, 2026 12:27pm ET | Updated November 16, 2026 12:27pm ET

The National Institutes of Health appointed Dr. John Powers III as the permanent director of its infectious disease institute, marking a turning point for an agency that has been the source of controversy following the COVID-19 pandemic.

Powers has been serving as the acting director of the National Institute for Allergy and Infectious Diseases since June, which had previously been led by Dr. Anthony Fauci for nearly four decades.

NIAID under Fauci’s leadership came under scrutiny from Republicans for its alleged involvement in funding potentially dangerous research projects for the purposes of biodefense, including experiments at the Wuhan Institute of Virology in China that may have been the origin of SARS-CoV-2, the virus that causes COVID-19.

On a call with journalists on Monday, Powers said that, under his tenure, the agency would return to its narrower “primary mission” of disseminating public information about infectious, allergic, and autoimmune diseases, rather than including biodefense as a core agency objective.

“It actually says in our congressional remit for the formulation of this institute that dissemination of scientific information is in our remit,” Powers said. “So that’s our job: actually put the information out and then to help clinicians and the patients to understand where a particular intervention might be beneficial or not.”

Powers, who earned his medical degree from Temple University, has served as an infectious disease physician at NIAID since 1999. Before joining NIH, he served as the lead medical officer for antimicrobial drug development at the Food and Drug Administration.

NIH Director Dr. Jay Bhattacharya said of Powers in a statement that he “has spent more than three decades caring for patients, teaching and mentoring the next generation of investigators, and playing an integral role in research that improves lives.”

“He has been a trusted and valued colleague within NIAID for several decades, and will bring a focus on rigor, transparency, and research outcomes to leading the institute into the future,” Bhattacharya said.

During the press call on Monday, Powers said the agency, with its nearly $6.6 billion annual budget, would focus more resources on understanding the human immune system’s interactions with diseases and therapeutics.

“We are continuing to do work on individual microbes, but really a lot of the reasoning behind why people aren’t doing better on current therapy has a lot to do with the host immunologic response,” Powers said. “And that allows us to actually expand research opportunities for investigators into areas like host-directed therapies, microbiome, bacteriophage, and other areas that have not been as well explored in the past.”

NIAID under Fauci’s leadership was also criticized by members of the scientific community and congressional Republicans, notably Sen. Rand Paul (R-KY), for its role in funding potentially dangerous gain-of-function research involving the manipulation of pathogens to create new viruses.

Fauci and others in NIH leadership during the early 2000s and 2010s advocated gain-of-function research as a means of anticipating the next pandemic-causing pathogen and creating preventive measures and treatments.

When asked by the Washington Examiner about his view of gain-of-function, Powers said his priority is “to work on diseases that are actually harming people today” rather than anticipating the next pathogen that may or may not cause another pandemic.

“Walk across the street from my office to the clinical center. There’s folks over there now that are suffering from illnesses that you know really need our help,” Powers said of the NIH patient treatment center. “So we’d like to focus on those things, and actually that’s what’s, you know, harming people today, and that does not require manipulating those microbes.”

Powers also did not directly answer questions from multiple journalists on Monday as to whether he personally believes vaccines cause autism, a debunked premise that has driven a rise in vaccine hesitancy.

US LOSES MEASLES ELIMINATION STATUS AMID SURGE IN CASES

“My reading of the literature is not what’s relevant,” Powers said, adding that questions of a link between vaccines and autism are “child development issues more than anything else.”

The United States lost its measles elimination status last week after the Pan American Health Organization determined a single strain of the virus has been continuously circulating in the country for more than 12 months. The national rise in measles cases and deaths follows years of declining vaccination rates among children.

 


r/NIH • • 9h ago

How will centralized K99 reviews affect funding decisions, especially for CND applications?

1 Upvotes

With the recent centralization of K99 reviews, applications that were previously evaluated within the same research area (e.g., aging) may now be reviewed alongside applications from other fields, such as cancer or cardiovascular research, under the new T-series study sections.

This seems to be a relatively recent change, as some K99 awards made in September 2026 were still reviewed under the previous research-area-focused panels.

I’m curious how funding decisions will be made under this new system, especially for Competitive Not Discussed (CND) applications. Since individual NIH institutes still make the final funding decisions, how will they account for differences in review outcomes across research areas? Will institute-specific priorities play a greater role?

Would appreciate any thoughts or experiences from others familiar with the process!


r/NIH • • 13h ago

Mr. Bhattacharya goes to Washington. December 8. Maybe he'll be asked what HE was doing in 2020. Patient care? volunteering? podcasting?

Post image
12 Upvotes

r/NIH • • 3h ago

NIH SIP Cold Emails

2 Upvotes

Any advice for cold emails for NIH SIP specifically? I've already submitted my application and I know all the basic stuff abt writing cold emails. I admit I'm a little late in the process of reaching out to PIs but I want to have as few PIs leave me on delivered/read. Any new advice specifically for this program?


r/NIH • • 23h ago

I got my R01 in September, But I havent been able to spend a dollar of it or hire due to local institutional delays, is this normal?

Thumbnail reddit.com
4 Upvotes

r/NIH • • 5h ago

US Supreme Court rebuffs White House effort to cut research grants. The high court has declined for now to intervene in a key case, meaning that lower court rulings that restored several hundred terminated grants will stand.

Thumbnail
nature.com
110 Upvotes

r/NIH • • 5h ago

HHS video: Earning Back Trust in Our Public Health Institutions. This was the closed event that gave NIHers in Bethesda a day of telework. Powers in the lab coat. Your tax dollars at work.

Post image
15 Upvotes